In this study, we explored the major ligands and receptors of the MK signaling pathway, such as MDK-NCL, which were involved in the progression of various cancers, including lung cancer, breast cancer, liver cancer, gastric cancer, and colorectal cancer (110). This evidence concerns the gene MDK and gastric cancer.